Mind Medicine (MindMed), Inc.
(NASDAQ: MNMD)

Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

12.035

-0.395 (-3.18%)
Range 12.030 - 12.680   (5.40%)
Open 12.460
Previous Close 12.430
Bid Price 3.520
Bid Volume 10
Ask Price -
Ask Volume 10
Volume 656,890
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 01:07.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis